步长制药：控股子公司山东丹红拟与山东中医药大学附属医院签署技术转让合同

Group 1 - Company announced that its subsidiary, Shandong Danhong, plans to sign a technology transfer contract with Shandong University of Traditional Chinese Medicine Affiliated Hospital for 15 million RMB to acquire the ownership of a traditional Chinese medicine formula for new drug development [2] - The transaction does not constitute a related party transaction or a major asset restructuring and has been approved by the company's fifth board of directors at the 29th meeting, thus does not require shareholder approval [2]